Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of inhaled Technosphere insulin versus oral antidiabetic combination therapy in type 2 diabetes
2006-002245-36Phase 3Completed
- Sponsor
- MannKind
- Start
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in type 2 diabetes mellitus (T2DM) comparing Technosphere insulin + metformin, Technosphere insulin alone and Metformin + secretagogue control (3 arms). Primary endpoint: Change in glycated hemoglobin. Started Oct 2006; status: completed.
02
Drugs
Technosphere insulinmetformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2006-002245-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002245-36.